AYTU BIOPHARMA, INC Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Aytu Biopharma, Inc annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from Q4 2010 to Q3 2023.
  • Aytu Biopharma, Inc Net Cash Provided by (Used in) Investing Activities for the quarter ending September 30, 2023 was -$76K, a 281% decline year-over-year.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$329K, a 181% decline from 2023.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$117K, a 96.4% increase from 2022.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$3.25M, a 16.8% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$76K -$118K -281% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q3 2022 $42K +$128K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q3 2021 -$86K -$77K -856% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-02-21
Q3 2020 -$9K +$1.03M +99.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q3 2019 -$1.04M -$739K -244% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q3 2018 -$303K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q4 2011 $0 $0 Sep 1, 2011 Nov 30, 2011 10-Q 2011-12-23
Q4 2010 $0 Sep 1, 2010 Nov 30, 2010 10-Q 2011-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.